HEALTHPEAK PROPERTIES INC (PEAK) Fundamental Analysis & Valuation

NYSE:PEAK • US42250P1030

Current stock price

17.1 USD
+0.35 (+2.09%)
At close:
17.1 USD
0 (0%)
After Hours:

This PEAK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PEAK Profitability Analysis

1.1 Basic Checks

  • PEAK had positive earnings in the past year.
  • In the past year PEAK had a positive cash flow from operations.
  • In the past 5 years PEAK has always been profitable.
  • In the past 5 years PEAK always reported a positive cash flow from operatings.
PEAK Yearly Net Income VS EBIT VS OCF VS FCFPEAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

1.2 Ratios

  • With a decent Return On Assets value of 1.94%, PEAK is doing good in the industry, outperforming 65.60% of the companies in the same industry.
  • PEAK has a better Return On Equity (4.79%) than 68.80% of its industry peers.
  • PEAK has a Return On Invested Capital (2.45%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PEAK is in line with the industry average of 3.11%.
  • The last Return On Invested Capital (2.45%) for PEAK is above the 3 year average (2.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROIC 2.45%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
PEAK Yearly ROA, ROE, ROICPEAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

  • The Profit Margin of PEAK (13.95%) is better than 68.00% of its industry peers.
  • In the last couple of years the Profit Margin of PEAK has declined.
  • Looking at the Operating Margin, with a value of 20.53%, PEAK is in line with its industry, outperforming 49.60% of the companies in the same industry.
  • PEAK's Operating Margin has declined in the last couple of years.
  • PEAK's Gross Margin of 59.28% is on the low side compared to the rest of the industry. PEAK is outperformed by 73.60% of its industry peers.
  • PEAK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
PEAK Yearly Profit, Operating, Gross MarginsPEAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

1

2. PEAK Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PEAK is destroying value.
  • The number of shares outstanding for PEAK remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, PEAK has a worse debt to assets ratio.
PEAK Yearly Shares OutstandingPEAK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
PEAK Yearly Total Debt VS Total AssetsPEAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.34, we must say that PEAK is in the distress zone and has some risk of bankruptcy.
  • PEAK has a Altman-Z score of 0.34. This is in the lower half of the industry: PEAK underperforms 64.80% of its industry peers.
  • PEAK has a debt to FCF ratio of 32.87. This is a negative value and a sign of low solvency as PEAK would need 32.87 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 32.87, PEAK perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
  • A Debt/Equity ratio of 1.08 is on the high side and indicates that PEAK has dependencies on debt financing.
  • The Debt to Equity ratio of PEAK (1.08) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Altman-Z 0.34
ROIC/WACC0.37
WACC6.55%
PEAK Yearly LT Debt VS Equity VS FCFPEAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

  • PEAK has a Current Ratio of 0.14. This is a bad value and indicates that PEAK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.14, PEAK is doing worse than 96.80% of the companies in the same industry.
  • PEAK has a Quick Ratio of 0.14. This is a bad value and indicates that PEAK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PEAK has a Quick ratio of 0.14. This is amonst the worse of the industry: PEAK underperforms 96.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
PEAK Yearly Current Assets VS Current LiabilitesPEAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

4

3. PEAK Growth Analysis

3.1 Past

  • PEAK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.86%.
  • The earnings per share for PEAK have been decreasing by -23.30% on average. This is quite bad
  • Looking at the last year, PEAK shows a small growth in Revenue. The Revenue has grown by 5.81% in the last year.
  • PEAK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.86% yearly.
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.48% on average over the next years.
  • PEAK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.55% yearly.
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PEAK Yearly Revenue VS EstimatesPEAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
PEAK Yearly EPS VS EstimatesPEAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

2

4. PEAK Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 30.54, the valuation of PEAK can be described as expensive.
  • PEAK's Price/Earnings ratio is a bit cheaper when compared to the industry. PEAK is cheaper than 61.60% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.60, PEAK is valued at the same level.
  • PEAK is valuated quite expensively with a Price/Forward Earnings ratio of 43.73.
  • Based on the Price/Forward Earnings ratio, PEAK is valued a bit cheaper than the industry average as 65.60% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of PEAK to the average of the S&P500 Index (22.84), we can say PEAK is valued expensively.
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
PEAK Price Earnings VS Forward Price EarningsPEAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PEAK is valued a bit cheaper than the industry average as 62.40% of the companies are valued more expensively.
  • PEAK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 44.73
EV/EBITDA 13.46
PEAK Per share dataPEAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • PEAK's earnings are expected to decrease with -5.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%

5

5. PEAK Dividend Analysis

5.1 Amount

  • PEAK has a Yearly Dividend Yield of 7.02%, which is a nice return.
  • PEAK's Dividend Yield is a higher than the industry average which is at 7.54.
  • Compared to an average S&P500 Dividend Yield of 1.88, PEAK pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.02%

5.2 History

  • The dividend of PEAK decreases each year by -11.76%.
  • PEAK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-11.76%
Div Incr Years0
Div Non Decr Years0
PEAK Yearly Dividends per sharePEAK Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

  • 215.92% of the earnings are spent on dividend by PEAK. This is not a sustainable payout ratio.
  • PEAK's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP215.92%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
PEAK Yearly Income VS Free CF VS DividendPEAK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B
PEAK Dividend Payout.PEAK Dividend Payout, showing the Payout Ratio.PEAK Dividend Payout.PayoutRetained Earnings

PEAK Fundamentals: All Metrics, Ratios and Statistics

HEALTHPEAK PROPERTIES INC

NYSE:PEAK (3/1/2024, 8:04:00 PM)

After market: 17.1 0 (0%)

17.1

+0.35 (+2.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-08
Earnings (Next)N/A
Inst Owners117.78%
Inst Owner Change-1.11%
Ins Owners0.15%
Ins Owner Change0%
Market Cap9.36B
Revenue(TTM)2.18B
Net Income(TTM)304.29M
Analysts78.18
Price Target22.19 (29.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.02%
Yearly Dividend1.2
Dividend Growth(5Y)-11.76%
DP215.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.48%
Min EPS beat(2)25.88%
Max EPS beat(2)43.09%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-17.64%
Max EPS beat(4)149.96%
EPS beat(8)6
Avg EPS beat(8)80.62%
EPS beat(12)9
Avg EPS beat(12)65.46%
EPS beat(16)12
Avg EPS beat(16)81.29%
Revenue beat(2)1
Avg Revenue beat(2)-0.5%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-1.62%
Max Revenue beat(4)0.62%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)3
Avg Revenue beat(12)-1.7%
Revenue beat(16)3
Avg Revenue beat(16)-8.89%
PT rev (1m)-1.34%
PT rev (3m)2.46%
EPS NQ rev (1m)-15.62%
EPS NQ rev (3m)-7.95%
EPS NY rev (1m)-12.55%
EPS NY rev (3m)-6.5%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)6.65%
Revenue NY rev (3m)16.7%
Valuation
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
P/S 4.29
P/FCF 44.73
P/OCF 9.78
P/B 1.47
P/tB 1.55
EV/EBITDA 13.46
EPS(TTM)0.56
EY3.27%
EPS(NY)0.39
Fwd EY2.29%
FCF(TTM)0.38
FCFY2.24%
OCF(TTM)1.75
OCFY10.22%
SpS3.99
BVpS11.61
TBVpS11.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROCE 3.1%
ROIC 2.45%
ROICexc 2.47%
ROICexgc 2.68%
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
FCFM 9.59%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
ROICexc(3y)2.16%
ROICexc(5y)1.9%
ROICexgc(3y)2.33%
ROICexgc(5y)2.05%
ROCE(3y)2.71%
ROCE(5y)2.39%
ROICexgc growth 3Y28.26%
ROICexgc growth 5Y4.6%
ROICexc growth 3Y28.51%
ROICexc growth 5Y3.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Debt/EBITDA 5.74
Cap/Depr 99.62%
Cap/Sales 34.25%
Interest Coverage 2.38
Cash Conversion 79.85%
Profit Quality 68.75%
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 0.34
F-Score6
WACC6.55%
ROIC/WACC0.37
Cap/Depr(3y)183.97%
Cap/Depr(5y)234.29%
Cap/Sales(3y)65.04%
Cap/Sales(5y)98.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A
EBIT growth 1Y13.63%
EBIT growth 3Y27.09%
EBIT growth 5Y6.6%
EBIT Next Year208.15%
EBIT Next 3Y49.06%
EBIT Next 5Y31.97%
FCF growth 1Y249.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.21%
OCF growth 3Y8.03%
OCF growth 5Y2.41%

HEALTHPEAK PROPERTIES INC / PEAK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to PEAK.


What is the valuation status of HEALTHPEAK PROPERTIES INC (PEAK) stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (PEAK). This can be considered as Overvalued.


How profitable is HEALTHPEAK PROPERTIES INC (PEAK) stock?

HEALTHPEAK PROPERTIES INC (PEAK) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for PEAK stock?

The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (PEAK) is 30.54 and the Price/Book (PB) ratio is 1.47.


How financially healthy is HEALTHPEAK PROPERTIES INC?

The financial health rating of HEALTHPEAK PROPERTIES INC (PEAK) is 1 / 10.